Plans4Care: Personalized Dementia Care On-Demand

Plans4Care:按需个性化痴呆症护理

基本信息

  • 批准号:
    10758864
  • 负责人:
  • 金额:
    $ 50万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-09-01 至 2024-08-31
  • 项目状态:
    已结题

项目摘要

PROJECT ABSTRACT Although >11 million family/friends are caregivers to >6 million people with Alzheimer's Disease (AD) and AD- Related Dementias (AD/ADRD), they do not typically receive personalized education, strategies and support to manage their own wellbeing and complex dementia-related symptoms. Lack of personalized care contributes to $321 billion annually in AD/ADRD care costs. In response, our company, Plans4Care, Inc, proposes a Fast- Track SBIR (PAS-22-196) to build and test a digital platform that delivers personalized care plans to caregivers on a smartphone, tablet or computer. To generate a personalized care plan, caregivers select a care challenge (from >50) they seek to address, and respond to brief, easy-to-answer questions (assessment). A novel clinical algorithm, developed by Plans4Care, maps the challenge and assessment results to the company’s database of >1,000 evidence-based strategies. A resultant personalized care plan contains education about the care challenge and specific strategies modifying the environment, communications, tasks, and/or activities. Caregivers also have access to trained dementia specialists (care advisors) for one-on-one tele-support as needed. Phase I will develop and evaluate a prototype. Phase I specific aims include: Aim 1: Develop a clickable prototype with clinical algorithms that map 5 common care challenges to brief assessments and evidence-based strategies to generate tailored care plans; and Aim 2: Determine feasibility (able to use platform to identify challenge/generate care plan), acceptability (appeal, appropriateness), and usability (able to navigate), using focus group and survey methodologies involving validated measures with 25 diverse caregivers (racially, ethnically, age, relationship, geography). At the conclusion of Phase I, quantitative milestones (go-no go) to transition to Phase II are: 1) 25 caregivers enrolled; 2) 75% complete assigned Plans4Care task: onboard, identify care challenge, generate care plan (feasibility); 3) 75% rate Plans4Care acceptable; and 4) 75% rate navigation easy-to-use (usability). During Phase II, we will ascertain if embedding Plans4Care into large geriatric primary care practices (part of accountable care organizations) results in improved caregiver wellbeing and reduced acute care utilization by people with AD/ADRD, and a commercially viable product. Phase II specific aims include: Aim 3: Incorporate Phase I feasibility feedback to complete the build out of the platform to address all 50+ care challenges, and develop our solution into a commercial product; and Aim 4: Conduct a two-group randomized controlled trial (n=160) to evaluate if Plans4Care improves diverse caregivers’ wellbeing and reduces acute care utilization of people with dementia. This aim will formally provide evidence for the platform and its implementation in primary care/ACOs. Our company was competitively selected to participate in the NIA Healthy Aging Start-Up Bootcamp. The commercialization potential of an easy-to-use tool providing personalized care that is integrated into ACOs is unique and desperately needed in the marketplace.
项目摘要 尽管>1100万家庭/朋友是600万阿尔茨海默病(AD)患者和AD患者的照顾者。 相关痴呆症(AD/ADRD),他们通常不会接受个性化的教育、战略和支持 管理自己的健康和复杂的痴呆症相关症状。缺乏个性化护理是原因之一 到每年3,210亿美元的AD/ADRD护理费用。作为回应,我们公司Plans4Care,Inc.提出了一项快速- 跟踪SBIR(PAS-22-196)以构建和测试向护理人员提供个性化护理计划的数字平台 在智能手机、平板电脑或电脑上。为了生成个性化护理计划,护理人员选择护理挑战 (来自>50)他们寻求解决并回答简短、易于回答的问题(评估)。一种新的临床应用 由Plans4Care开发的算法将挑战和评估结果映射到公司的数据库 1,000种基于证据的战略。由此产生的个性化护理计划包含有关护理的教育 挑战和修改环境、通信、任务和/或活动的具体战略。 照顾者还可以获得训练有素的痴呆症专家(护理顾问)的一对一远程支持 需要的。第一阶段将开发和评估原型。第一阶段的具体目标包括:目标1:制定 带有临床算法的可点击原型,可将5个常见护理挑战映射到简要评估和 基于证据的战略,以生成量身定制的护理计划;和目标2:确定可行性(能够使用 确定挑战/生成护理计划的平台)、可接受性(吸引力、适当性)和可用性(能够 导航),使用焦点小组和调查方法,涉及25种不同的有效衡量标准 照顾者(种族、民族、年龄、关系、地理)。在第一阶段结束时,量化 过渡到第二阶段的里程碑(通过-不通过)是:1)注册25名护理员;2)完成75%的分配 计划4护理任务:入职,确定护理挑战,制定护理计划(可行性);3)75%的计划4护理 可接受;以及4)75%的导航易用性(可用性)。在第二阶段,我们将确定是否嵌入 将护理纳入大型老年初级保健实践(负责任的护理组织的一部分)的结果是 改善照顾者福祉,降低AD/ADRD患者的急性护理利用率,并在商业上 可行的产品。第二阶段的具体目标包括:目标3:将第一阶段的可行性反馈纳入完成 构建平台以应对所有50多项护理挑战,并将我们的解决方案开发为商业解决方案 目标4:进行两组随机对照试验(n=160),以评估是否有Plans4Care 改善不同照顾者的福祉,减少痴呆症患者的急性护理利用率。这一目标 将正式为该平台及其在初级保健/初级保健中心的实施提供证据。我们的公司是 竞争被选中参加NIA健康老龄化初创企业训练营。商业化 集成到ACOS中的提供个性化护理的易于使用的工具的潜力是独一无二的 市场上迫切需要的。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Eric Jutkowitz其他文献

Eric Jutkowitz的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Eric Jutkowitz', 18)}}的其他基金

Evaluating the Impact of COVID-19 on Case Management, Health Care Utilization, and Housing Outcomes for HUD-VASH Veterans
评估 COVID-19 对 HUD-VASH 退伍军人的病例管理、医疗保健利用和住房结果的影响
  • 批准号:
    10641154
  • 财政年份:
    2023
  • 资助金额:
    $ 50万
  • 项目类别:
Memory Care in Assisted Living: Does it Improve Quality Outcomes?
辅助生活中的记忆护理:它能提高质量结果吗?
  • 批准号:
    10807400
  • 财政年份:
    2023
  • 资助金额:
    $ 50万
  • 项目类别:
Person-Reported and Health Care Utilization Outcomes of Home and Community Based Care Recipients With and Without Alzheimer's Disease and its Related Dementias
患有和不患有阿尔茨海默病及其相关痴呆症的家庭和社区护理接受者的个人报告和医疗保健利用结果
  • 批准号:
    10092440
  • 财政年份:
    2020
  • 资助金额:
    $ 50万
  • 项目类别:
Did Covid and the Transition to Telehealth Change Person-Reported Outcomes for Home and Community Based Care Recipients With and Without Alzheimer's Disease and its Related Dementias?
新冠疫情和向远程医疗的转变是否改变了患有或不患有阿尔茨海默病及其相关痴呆症的家庭和社区护理接受者的个人报告结果?
  • 批准号:
    10863580
  • 财政年份:
    2020
  • 资助金额:
    $ 50万
  • 项目类别:
Microsimulation Modeling to Compare the Effectiveness and Cost-Effectiveness of Nondrug Interventions to Manage Clinical Symptoms in Racially/Ethnically Diverse Persons with Dementia
微观模拟模型比较非药物干预措施管理不同种族/民族痴呆症患者临床症状的有效性和成本效益
  • 批准号:
    10417166
  • 财政年份:
    2019
  • 资助金额:
    $ 50万
  • 项目类别:
Microsimulation Modeling to Compare the Effectiveness and Cost-Effectiveness of Nondrug Interventions to Manage Clinical Symptoms in Racially/Ethnically Diverse Persons with Dementia
微观模拟模型比较非药物干预措施管理不同种族/民族痴呆症患者临床症状的有效性和成本效益
  • 批准号:
    10218006
  • 财政年份:
    2019
  • 资助金额:
    $ 50万
  • 项目类别:
Informal Resources of Persons Living with Alzheimer's Disease and Related Dementias: Impact on Hospitalizations, Potentially Avoidable Hopsitalizations and Nursing Home Admissions
阿尔茨海默病和相关痴呆症患者的非正式资源:对住院治疗、可能可以避免的住院治疗和疗养院入院的影响
  • 批准号:
    9789802
  • 财政年份:
    2018
  • 资助金额:
    $ 50万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 50万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 50万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 50万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 50万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 50万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 50万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 50万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 50万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 50万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 50万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了